Amide Derivatives and Their Metal Complexes as Potential Nav1.7-Targeting Anesthetic Candidates

Temitayo O. Aiyelabola^1, , Sayantan Pradhan^2, and Takashiro Akitsu³

¹Department of Chemistry, Faculty of Science, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria

²Chemical Science Division, Saha Institute of Nuclear Physics, Kolkata, West Bengal, India

³Department of Chemistry, Faculty of Science, Tokyo University of Science, 1-3 Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan

Cite this paper:
Temitayo O. Aiyelabola, Sayantan Pradhan and Takashiro Akitsu. Amide Derivatives and Their Metal Complexes as Potential Nav1.7-Targeting Anesthetic Candidates. American Journal of Biomedical Research. 2026; 14(1):8-15. doi: 10.12691/ajbr-14-1-2

Abstract

Voltage-gated sodium (Nav) channels are important pharmacological targets, with Nav1.7 playing a central role in pain signaling. Unlike conventional pore blockers, aryl sulfonamide gating modifiers target the voltage-sensing domain 4 (VSD4) through a state-dependent voltage-sensor trapping mechanism, preferentially interacting with the activated VSD4 and its R4 gating-charge residue. Targeting the relatively less-conserved VSD4 region may offer greater Nav1.7 isoform selectivity and reduced off-target effects. In this study, molecular docking was employed to investigate the interactions of two amide ligands and their corresponding copper(II) and cobalt(II) complexes with human Nav1.7 VSD4, using the selective VSD4 inhibitor GX-936 as a reference. Docking was performed using AutoDock following standard receptor and ligand preparation procedures. Among the investigated compounds, Cobalt Amide ligand 1 yielded the most negative docking score among the tested compounds. Cobalt Amide ligand 1 formed multiple predicted hydrogen-bonding electrostatic, π–π and hydrophobic interactions with key VSD4 residues, including Tyr1537, Trp1538, Arg1602, Arg1605, and particularly Arg1608, with a predicted electrostatic interaction distance of 4.48 Å. The better docking behavior of the cobalt complex may be associated with metal coordination-induced changes in molecular geometry, electronic distribution, and conformational properties. Overall, these findings identify Cobalt Amide ligand 1 as a promising candidate for further investigation as a Nav1.7 VSD4 modulator, with potential applications in the development of novel analgesic or anesthetic agents

Keywords:
Voltage-gated sodium channel Nav1.7 molecular docking amide ligand copper complex cobalt complex local anesthetic

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Catterall WA. Voltage-gated sodium channels at 60: structure, function and pathophysiology. The Journal of Physiology. 2012; 590: 2577–2589.
[2]	Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000; 26: 13–25.
[3]	Dib-Hajj SD, Yang Y, Black JA, Waxman SG. The NaV1.7 sodium channel: from molecule to man. Nature Reviews Neuroscience. 2013; 14: 49–62.
[4]	Hille B. Ion Channels of Excitable Membranes. 3rd ed. Sunderland, MA: Sinauer Associates; 2001.
[5]	Ahuja S, Mukund S, Deng L, et al. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science. 2015; 350(6267): aac5464.
[6]	Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006; 444: 894–898.
[7]	Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesthesia Progress. 2012; 59: 90–102.
[8]	Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. British Journal of Anaesthesia. 2002; 89: 52–61.
[9]	Butterworth JF. Models and mechanisms of local anesthetic action. Journal of Clinical Anesthesia. 1989; 1: 275–284.
[10]	Gasser G, Metzler-Nolte N. The potential of organometallic complexes in medicinal chemistry. Current Opinion in Chemical Biology. 2012; 16: 84–91.
[11]	Barry NPE, Sadler PJ. Exploration of the medical periodic table: towards new targets. Chemical Communications. 2013; 49: 5106–5131.
[12]	Kostova I. Ruthenium complexes as anticancer agents. Current Medicinal Chemistry. 2006; 13: 1085–1107.
[13]	Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009; 30: 2785–2791.
[14]	Goodsell DS, Olson AJ. Automated docking of substrates to proteins by simulated annealing. Proteins. 1990; 8: 195–202.
[15]	Aiyelabola TO, Pradhan S, Akitsu T. Synthesis, characterization and anti-inflammatory activity of two novel amides and their Cu(II) and Co(II) complexes. ES Chemistry and Sustainability. 2026; 7: 2195.
[16]	Sanner MF. Python: a programming language for software integration and development. Journal of Molecular Graphics and Modelling. 1999; 17: 57–61.
[17]	Roopashree B. A review study on computational insights into transition metal complex cytotoxicity in neurobiology. Developmental Neurobiology. 2025.
[18]	Margariti A, Papakonstantinou VD, Stamatakis G, et al. First-row transition metal complexes incorporating the 2-(2′-pyridyl)quinoxaline ligand (pqx), as potent inflammatory mediators: cytotoxic properties and biological activities against the platelet-activating factor (PAF) and thrombin. Molecules. 2023; 28: 6899.
[19]	Pöthig A, Casini A. Recent developments of supramolecular metal-based structures for applications in cancer therapy and imaging. Theranostics. 2019; 9: 3150–3169.
[20]	Zhang R, Pan Y, Ahmed L, et al. A multispecific investigation of the metal effect in mammalian odorant receptors for sulfur-containing compounds. Chemical Senses. 2018; 43: 357–366.